Koyfin Home > Directory > Health Care > Adamas Pharma > Net Income

Adamas Pharma Net Income Chart (ADMS)

Adamas Pharma annual/quarterly Net Income from 2012 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Adamas Pharma Net Income for the quarter ending June 06, 2020 was $-11m a -161.04% increase of 17m year over year
  • Adamas Pharma Net Income for the last 12 months ending June 06, 2020 was $-78m a -42.54% increase of 33m year over year
  • Adamas Pharma Annual Net Income for 2019 was $-105m a -24.54% increase of 26m from 2018
  • Adamas Pharma Annual Net Income for 2018 was $-131m a 31.69% decrease of -42m from 2017
  • Adamas Pharma Annual Net Income for 2017 was $-89m a 32.89% decrease of -29m from 2016
Other Income Statement Metrics:
  • Adamas Pharma EBITDA for the quarter ending December 12, 2018 was $-25m a -22.88% increase of 6m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Net Income Data

06/2020$-11m
03/2020$-17m
12/2019$-23m
09/2019$-28m
06/2019$-25m
03/2019$-30m
12/2018$-29m
09/2018$-33m
06/2018$-34m
03/2018$-35m

Annual ADMS Net Income Data

2019$-105m
2018$-131m
2017$-89m
2016$-60m
2015$-52m
2014$10m
2013$51m
2012$18m
2011$-8m